umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Show others and affiliations
2013 (English)In: Breast Cancer Research, ISSN 1465-5411, E-ISSN 1465-542X, Vol. 15, no 1, R15- p.Article in journal (Refereed) Published
Abstract [en]

Introduction: Experimental evidence suggests a protective role for circulating 25-hydroxyvitamin D (25(OH) D) in breast cancer development, but the results of epidemiological studies have been inconsistent.

Methods: We conducted a case-control study nested within two prospective cohorts, the New York University Women's Health Study and the Northern Sweden Mammary Screening Cohort. Blood samples were collected at enrollment, and women were followed up for breast cancer ascertainment. In total, 1,585 incident breast cancer cases were individually-matched to 2,940 controls. Of these subjects, 678 cases and 1,208 controls contributed two repeat blood samples, at least one year apart. Circulating levels of 25(OH) D were measured, and multivariate odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using conditional logistic regression.

Results: No association was observed between circulating levels of 25(OH) D and overall breast cancer risk (multivariate-adjusted model OR = 0.94, 95% CI = 0.76-1.16 for the highest vs. lowest quintile, ptrend = 0.30). The temporal reliability of 25(OH)D measured in repeat blood samples was high (intraclass correlation coefficients for season-adjusted 25(OH) D > 0.70). An inverse association between 25(OH) D levels and breast cancer risk was observed among women who were = 45 years of age (ORQ5-Q1 = 0.48, 95% CI = 0.30-0.79, ptrend = 0.01) or premenopausal at enrollment (ORQ5-Q1 = 0.67, 95% CI = 0.48-0.92, ptrend = 0.03).

Conclusions: Circulating 25(OH) D levels were not associated with breast cancer risk overall, although we could not exclude the possibility of a protective effect in younger women. Recommendations regarding vitamin D supplementation should be based on considerations other than breast cancer prevention.

Place, publisher, year, edition, pages
2013. Vol. 15, no 1, R15- p.
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-76821DOI: 10.1186/bcr3390ISI: 000320158100024OAI: oai:DiVA.org:umu-76821DiVA: diva2:636984
Available from: 2013-07-15 Created: 2013-07-15 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

fulltext(346 kB)124 downloads
File information
File name FULLTEXT02.pdfFile size 346 kBChecksum SHA-512
ffac08a196b28ae806009aa8f13668de6fb3dc128da32858f3c6c009312cf3ee458554004dac13591729eecc28f9e867375c888be7d35c85917da2c18c697af4
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Lenner, PerHallmans, Göran

Search in DiVA

By author/editor
Lenner, PerHallmans, Göran
By organisation
OncologyNutritional ResearchDepartment of Biobank Research
In the same journal
Breast Cancer Research
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 124 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 116 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf